{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T22:00:50Z","timestamp":1648504850786},"reference-count":28,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2003,10,9]],"date-time":"2003-10-09T00:00:00Z","timestamp":1065657600000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1034\/j.1399-3046.2003.00041.x","type":"journal-article","created":{"date-parts":[[2003,10,16]],"date-time":"2003-10-16T01:57:03Z","timestamp":1066269423000},"page":"376-380","source":"Crossref","is-referenced-by-count":3,"title":["Use of prophylactic lamivudine and mycophenolate mofetil in renal transplant recipients with chronic hepatitis B infection"],"prefix":"10.1034","volume":"7","author":[{"given":"S. C.","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. C.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. M.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,9]]},"reference":[{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB1|cit2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0016-5085(88)90623-3","article-title":"Hepatitis B virus and hepatitis B-related infection in renal transplant recipients","volume":"94","author":"Degos","year":"1988","journal-title":"Gastroentrology"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB2|cit3","first-page":"1785","article-title":"The significance and implications of hepatitis B infection in renal transplant recipients","volume":"23","author":"Dhar","year":"1991","journal-title":"Transplant proc"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB3|cit4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00007890-199109000-00021","article-title":"The increased risk of fatal liver disease in renal transplant patients who are hepatitis Be antigen and\/or HBV DNA positive","volume":"52","author":"Fairley","year":"1991","journal-title":"Transplantation"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB4|cit5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00007890-199602150-00008","article-title":"Fibrosing cholestatic hepatitis in renal transplant recipients","volume":"61","author":"Lam","year":"1996","journal-title":"Transplantation"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB5|cit6","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1440-1746.1998.tb00589.x","article-title":"Fibrosing cholestatic hepatitis after living related-donor renal transplantation","volume":"13","author":"Waguri","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl","key":"10.1034\/j.1399-3046.2003.00041.x-BIB6|cit7","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/0264-410X(90)90209-5","article-title":"Hepatitis B global importance and need for control","volume":"8","author":"Maynard","year":"1990","journal-title":"Vaccine"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB7|cit8","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0041-1345(00)02405-2","article-title":"Long-term outcome in hepatitis B sero-positive oriental renal transplant recipients","volume":"33","author":"Wong","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB8|cit9","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/00007890-199712150-00025","article-title":"Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation","volume":"64","author":"Lionel","year":"1997","journal-title":"Transplantation"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB9|cit10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM199807093390201","article-title":"One-year trial of lamivudine for chronic hepatitis B","volume":"339","author":"Lai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB10|cit11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00007890-199809270-00007","article-title":"Treatment of chronic hepatitis B with lamivudine in renal transplant recipients","volume":"66","author":"Jung","year":"1998","journal-title":"Transplantation"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB11|cit12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00007890-199709270-00024","article-title":"Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine","volume":"64","author":"Al","year":"1997","journal-title":"Transplantation"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB12|cit13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00007890-200102150-00008","article-title":"Results on preemptive or prophylactic treatment of lamivudine in HbsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence","volume":"71","author":"Han Duck","year":"2001","journal-title":"Transplantation"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB13|cit14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0166-3542(00)00121-2","article-title":"Ribavirin and mycopheolic acid potentiate the activity of guanine and diaminopurine-based nucleoside analogues against hepatitis B virus","volume":"48","author":"Ying","year":"2000","journal-title":"Antiviral Res"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB14|cit15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00007890-199607270-00025","article-title":"The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection","volume":"62","author":"Fornarion","year":"1996","journal-title":"Transplantation"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB15|cit16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1159\/000189444","article-title":"Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C","volume":"74","author":"Rostaing","year":"1996","journal-title":"Nephron"},{"issue":"Suppl.","key":"10.1034\/j.1399-3046.2003.00041.x-BIB16|cit17","first-page":"15","article-title":"Alpha-interferon therapy for chronic hepatitis B virus infection in children and oriental patients","volume":"1","author":"Lok Anna","year":"1991","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB17|cit18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00007890-199808150-00025","article-title":"Lamivudine inhibits hepatitis B virus replication in kidney graft recipients","volume":"66","author":"Goffin","year":"1998","journal-title":"Transplantation"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB18|cit19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2893.1999.00163.x","article-title":"Mycopheonlic acid, an immunosuppressive agent, inhibits HBV replication in vitro","volume":"6","author":"Gong","year":"1999","journal-title":"J Hepat"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB19|cit20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.510310330","article-title":"Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong","volume":"31","author":"Chan Henry","year":"2000","journal-title":"Hepatology"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB20|cit21","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/hep.510270634","article-title":"Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy","volume":"27","author":"Kazuaki","year":"1998","journal-title":"Hepatology"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB21|cit22","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/00007890-200011150-00024","article-title":"Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients","volume":"70","author":"Kletzmayr","year":"2000","journal-title":"Transplantation"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB22|cit23","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1097\/00007890-200005270-00020","article-title":"HBV genotypic resistance to Lamivudine in kidney recipients and hemodialyzed patients","volume":"69","author":"Fontaine","year":"2000","journal-title":"Transplantation"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB23|cit24","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa012452","article-title":"Clinical trial of lamivudine in children with chronic hepatitis B","volume":"346","author":"Jonas Maureen","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB24|cit25","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1440-1746.2001.02578.x","article-title":"Hepatitis B surface antigen-positive organ transplantation recipients: can lamivudine alter their fate?","volume":"16","author":"Nancy","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB25|cit26","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/00007890-199612270-00013","article-title":"Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients","volume":"62","author":"Rao","year":"1996","journal-title":"Transplantation"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB26|cit27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/jhep.2000.9407","article-title":"A randomized placebo-controlled study to evaluate the efficacy of the 12-months famiciclovir treatment in patients with chronic Hbe-Ag-positive hepatitis B","volume":"32","author":"De Man","year":"2000","journal-title":"Hepatology"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB27|cit28","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1097\/00007890-199912270-00017","article-title":"Fulminant Hepatic Failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and Hepatitis B Immunglobulin","volume":"68","author":"Peters Marion","year":"1999","journal-title":"Transplantation"},{"key":"10.1034\/j.1399-3046.2003.00041.x-BIB28|cit29","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1097\/00007890-200004270-00039","article-title":"Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary report","volume":"69","author":"Seehofer","year":"2000","journal-title":"Transplantation"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-3046.2003.00041.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-3046.2003.00041.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1034\/j.1399-3046.2003.00041.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T18:31:57Z","timestamp":1625509917000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-3046.2003.00041.x"}},"subtitle":["<b>Prophylactic lamivudine and mycophenolate mofetil in renal transplant recipients<\/b>"],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,10]]}},"URL":"https:\/\/doi.org\/10.1034\/j.1399-3046.2003.00041.x","archive":["Portico"],"relation":{},"ISSN":["1397-3142"],"issn-type":[{"value":"1397-3142","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}